Aethlon Shareholders Equity Per Share from 2010 to 2024

AEMD Stock  USD 0.58  0.15  34.88%   
Aethlon Medical's Shareholders Equity Per Share is increasing over the years with slightly volatile fluctuation. Overall, Shareholders Equity Per Share is expected to go to 2.41 this year. During the period from 2010 to 2024 Aethlon Medical Shareholders Equity Per Share annual values regression line had coefficient of variation of (320.36) and r-squared of  0.18. View All Fundamentals
 
Shareholders Equity Per Share  
First Reported
2010-12-31
Previous Quarter
2.29480725
Current Value
2.41
Quarterly Volatility
189.99546343
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aethlon Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aethlon Medical's main balance sheet or income statement drivers, such as Interest Expense of 158.4 M, Other Operating Expenses of 13.3 M or Total Operating Expenses of 12.9 M, as well as many indicators such as Price To Sales Ratio of 14.85, Dividend Yield of 0.0 or PTB Ratio of 0.79. Aethlon financial statements analysis is a perfect complement when working with Aethlon Medical Valuation or Volatility modules.
  
Check out the analysis of Aethlon Medical Correlation against competitors.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

Latest Aethlon Medical's Shareholders Equity Per Share Growth Pattern

Below is the plot of the Shareholders Equity Per Share of Aethlon Medical over the last few years. It is Aethlon Medical's Shareholders Equity Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aethlon Medical's overall financial position and show how it may be relating to other accounts over time.
Shareholders Equity Per Share10 Years Trend
Slightly volatile
   Shareholders Equity Per Share   
20.027.57.8011.67.342.292.4137%-72%49%-37%-69%5%100%
       Timeline  

Aethlon Shareholders Equity Per Share Regression Statistics

Arithmetic Mean(59.31)
Coefficient Of Variation(320.36)
Mean Deviation123.72
Median7.80
Standard Deviation190.00
Sample Variance36,098
Range652
R-Value0.43
Mean Square Error31,738
R-Squared0.18
Significance0.11
Slope18.20
Total Sum of Squares505,376

Aethlon Shareholders Equity Per Share History

2024 2.41
2023 2.29
2022 7.34
2021 11.61
2020 7.8
2019 27.55
2018 20.07

About Aethlon Medical Financial Statements

Aethlon Medical stakeholders use historical fundamental indicators, such as Aethlon Medical's Shareholders Equity Per Share, to determine how well the company is positioned to perform in the future. Although Aethlon Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aethlon Medical's assets and liabilities are reflected in the revenues and expenses on Aethlon Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aethlon Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Shareholders Equity Per Share 2.29  2.41 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:
Check out the analysis of Aethlon Medical Correlation against competitors.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.79)
Revenue Per Share
0.236
Quarterly Revenue Growth
42.782
Return On Assets
(0.50)
Return On Equity
(1.05)
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

RPID
Rapid Micro Biosystems
0.90  -0.1  -10 
OSA
ProSomnus, Common Stock
0.47  0.00  0.00 
DCTH
Delcath Systems
11.01  -0.17  -1.52 
HSCS
Heart Test Laboratories
3.83  0.41  11.99 
News Freq…Investor S…